Huimin Wang

Huimin Wang

Auto-generated profile, based on publicly available information

Huimin Wang

Affiliated Hospital of Nantong University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2009 in Cancer Science
Verified
Journal Article
Open access
PDF file
HGHongchang Gao
Hongchang Gao
QLQiang Lu
Qiang Lu
XLXia Liu
Xia Liu
HCHui Cong
Hui Cong
LZLiangcai Zhao
Liangcai Zhao
Dong-Hai LinDong-Hai Lin
Dong-Hai Lin
1H nuclear magnetic resonance (NMR)‐based metabonomics was used to characterize metabolic profiles of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). We found compared to healthy humans, LC and HCC sera had higher levels of acetate, N‐acetylglycoproteins, pyruvate, glutamine, α‐ketoglutarate, glycerol, tyrosine, 1‐methylhistidine and phenylalanine, together with lower levels of low‐density lipoprotein, isoleucine, valine, acetoacetate, creatine, choline and unsaturated lipids. Scores plot of pattern recognition analysis were capable of distinguishing LC and HCC patients from healthy humans. These results indicate that serum NMR spectra combined with pattern recognition analysis techniques offer an efficient, convenient way of depicting tumor biochemistry, which may be of great benefit to early diagnosis of human malignant diseases using single blood samples. (Cancer Sci 2009; 100: 782–785)

15 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKeke Shao
Keke Shao
WDWeifeng Ding
Weifeng Ding
FWFeng Wang
Feng Wang
HLHaiquan Li
Haiquan Li
DMDa Ma
Da Ma
HWHuimin Wang
Huimin Wang
Aptamers are short RNA or DNA oligonucleotides which can bind with different targets. Typically, they are selected from a large number of random DNA sequence libraries. The main strategy to obtain aptamers is systematic evolution of ligands by exponential enrichment (SELEX). Low efficiency is one of the limitations for conventional PCR amplification of random DNA sequence library in aptamer selection because of relative low products and high by-products formation efficiency. Here, we developed emulsion PCR for aptamer selection. With this method, the by-products formation decreased tremendously to an undetectable level, while the products formation increased significantly. Our results indicated that by-products in conventional PCR amplification were from primer-product and product-product hybridization. In emulsion PCR, we can completely avoid the product-product hybridization and avoid the most of primer-product hybridization if the conditions were optimized. In addition, it also showed that the molecule ratio of template to compartment was crucial to by-product formation efficiency in emulsion PCR amplification. Furthermore, the concentration of the Taq DNA polymerase in the emulsion PCR mixture had a significant impact on product formation efficiency. So, the results of our study indicated that emulsion PCR could improve the efficiency of SELEX.

1 November 2019 in Catalysis Communications
Verified
Journal Article
Closed access
QZQiulin Zhang
Qiulin Zhang
TTTong Tang
Tong Tang
Jing WangJing Wang
Jing Wang
MSMenghan Sun
Menghan Sun
HWHuimin Wang
Huimin Wang
PNPing Ning
Ping Ning

1 January 2011 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
FWFeng Wang
Feng Wang
LCLin Chen
Lin Chen
WDWeifeng Ding
Weifeng Ding
GWGuihua Wang
Guihua Wang
YWYueping Wu
Yueping Wu
HWHuimin Wang
Huimin Wang
A proliferation-inducing ligand (APRIL) is a newly-found member in the tumor necrosis factor (TNF) superfamily. Our previous studies have already confirmed that APRIL is overexpressed in pancreatic cancer tumors, however, it is not expressed or has a weak expression in normal pancreatic gland tissues. Furthermore, there is no report on serum APRIL in patients with pancreatic diseases. Herein, in order to explore the clinical implication of serum APRIL in patients with pancreatic cancer, serum APRIL, together with carcinoembryonic antigen (CEA) and carbohydrate antigen (CA)19-9, was examined. Serum APRIL was tested by ELISA in patients with pancreatic cancer. Meanwhile, two other conventional serum tumor markers, CEA and CA19-9, were measured by Elecsys 2010 Chemistry Analyzer. Serum APRIL increased in patients with pancreatic cancer, which proved a positive correlation with CEA and CA19-9. When the diagnosis of benign or malignant condition was examined by one tumor marker, the sensitivity of APRIL alone (70.1%) was greater than that of CEA alone (56.7%), and the specificity of APRIL alone (85.5%) was higher than that of CA19-9 alone (83.6%). When examined by a combination of two markers, the sensitivity of the combination of APRIL and CA19-9 was the highest (88.1%), as it was compared with that of APRIL alone, CEA alone and APRIL+CEA, p<0.05. In addition, serum APRIL also correlated with the tumor stage and postoperative survival in patients with pancreatic cancer. Our results indicate that serum APRIL, as a potential biomarker, has a positive diagnosis and prognosis value for pancreatic cancer. Moreover, the combination assay of APRIL and CA19-9 is highly sensitive to pancreatic cancer.

28 April 2008 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
HWHua Wang
Hua Wang
HWHui‐Min Wang
Hui‐Min Wang
JQJIN Qing-Hui
JIN Qing-Hui
HCHui Cong
Hui Cong
GZGui‐Sheng Zhuang
Gui‐Sheng Zhuang
WWWei Wang
Wei Wang

30 June 2009 in Clinical Biochemistry
Verified
Journal Article
Closed access
WDWeifeng Ding
Weifeng Ding
JWJinchun Wang
Jinchun Wang
BSBaolan Sun
Baolan Sun
SJShaoqing Ju
Shaoqing Ju
HYHongxiang Yuan
Hongxiang Yuan
HWHuimin Wang
Huimin Wang